← Back to Search

Physician-focused Behavioral Intervention for Prostate Cancer Imaging

N/A
Waitlist Available
Led By Danil V Makarov, MD MHS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 4 years
Awards & highlights

Study Summary

This trial is testing whether a multi-disciplinary, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of prostate cancer staging imaging.

Who is the study for?
This trial is for Urology Chiefs, attending urologists, Physician Assistants, and Nurse Practitioners at the VA who've treated at least 5 men with new prostate cancer in the last 6 months. It's not for residents or those over 85 years old, without certain medical data, a history of other cancers, or patients diagnosed post-mortem.Check my eligibility
What is being tested?
The study tests if a multi-part intervention aimed at doctors can make prostate cancer imaging more guideline-concordant. Methods include Clinical Order Checks to guide decisions, Academic Detailing for education on best practices, and Audit and Feedback to review physician performance.See study design
What are the potential side effects?
Since this trial focuses on physician behavior rather than direct patient treatments, it does not involve typical medication side effects. However, there may be indirect effects on patient care based on changes in imaging practices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Malignant Neoplasms
Facility-level inappropriate prostate cancer imaging rates
Secondary outcome measures
Individual-level appropriate prostate cancer imaging rates
Individual-level inappropriate prostate cancer imaging rates
Net cost of implementation of the behavioral intervention
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment3 Interventions
The intervention is comprised of three components: 1) Clinical Order Check, 2) Academic Detailing, and 3) Audit and Feedback.
Group II: ControlActive Control1 Intervention
No intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Academic Detailing
2003
Completed Phase 4
~80010
Audit and Feedback
2016
N/A
~85530

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,612 Previous Clinical Trials
3,305,685 Total Patients Enrolled
14 Trials studying Prostate Cancer
8,727 Patients Enrolled for Prostate Cancer
Danil V Makarov, MD MHSPrincipal InvestigatorManhattan Campus of the VA NY Harbor Healthcare System, New York, NY

Media Library

Clinical Order Check Clinical Trial Eligibility Overview. Trial Name: NCT03445559 — N/A
Prostate Cancer Research Study Groups: Intervention, Control
Prostate Cancer Clinical Trial 2023: Clinical Order Check Highlights & Side Effects. Trial Name: NCT03445559 — N/A
Clinical Order Check 2023 Treatment Timeline for Medical Study. Trial Name: NCT03445559 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for participants in this experiment?

"The trial data on clinicaltrials.gov reveals that this research is not currently enrolling patients, despite the study initially being posted in April 2018 and last updated in March of 2022. However, there are a plethora of other studies actively recruiting volunteers at present with 1,321 trials listed."

Answered by AI

What are the key aims of this research study?

"The primary focus of this medical trial is to evaluate the Facility-level rates of inappropriate prostate cancer imaging over a span of 4 years. Secondary objectives comprise a Budget impact analysis, an Individual-level assessment termed Inappropriate Imaging, and Qualitative outcomes derived from semi-structured provider interviews."

Answered by AI
Recent research and studies
~8 spots leftby May 2025